![Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA - Michael P. Hengartner, Martin Plöderl, 2021 Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA - Michael P. Hengartner, Martin Plöderl, 2021](https://journals.sagepub.com/cms/10.1177/20451253211032051/asset/images/large/10.1177_20451253211032051-fig1.jpeg)
Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA - Michael P. Hengartner, Martin Plöderl, 2021
![PDF) A Review: Integrative Perspectives on the Features and Clinical Management of Psychotic Episodes in Pregnancy PDF) A Review: Integrative Perspectives on the Features and Clinical Management of Psychotic Episodes in Pregnancy](https://i1.rgstatic.net/publication/367175342_A_Review_Integrative_Perspectives_on_the_Features_and_Clinical_Management_of_Psychotic_Episodes_in_Pregnancy/links/63c54c5dd9fb5967c2e00b44/largepreview.png)
PDF) A Review: Integrative Perspectives on the Features and Clinical Management of Psychotic Episodes in Pregnancy
![Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA - Michael P. Hengartner, Martin Plöderl, 2021 Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA - Michael P. Hengartner, Martin Plöderl, 2021](https://journals.sagepub.com/cms/10.1177/20451253211032051/asset/images/large/10.1177_20451253211032051-fig2.jpeg)
Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA - Michael P. Hengartner, Martin Plöderl, 2021
Strellson Trenchcoat, Dunkelblau, Gr. 52 in Düsseldorf - Bezirk 9 | eBay Kleinanzeigen ist jetzt Kleinanzeigen
![PDF) Antidepressant Use During Acute Inpatient Care Is Associated With an Increased Risk of Psychiatric Rehospitalisation Over a 12-Month Follow-Up After Discharge PDF) Antidepressant Use During Acute Inpatient Care Is Associated With an Increased Risk of Psychiatric Rehospitalisation Over a 12-Month Follow-Up After Discharge](https://i1.rgstatic.net/publication/331291529_Antidepressant_Use_During_Acute_Inpatient_Care_Is_Associated_With_an_Increased_Risk_of_Psychiatric_Rehospitalisation_Over_a_12-Month_Follow-Up_After_Discharge/links/5c70ada2458515831f67c555/largepreview.png)
PDF) Antidepressant Use During Acute Inpatient Care Is Associated With an Increased Risk of Psychiatric Rehospitalisation Over a 12-Month Follow-Up After Discharge
![Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis | Psychological Medicine | Cambridge Core Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis | Psychological Medicine | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20201214082817572-0306:S003329171900285X:S003329171900285X_fig3.png?pub-status=live)